RecruitingPhase 4NCT06356948

Rate of Tranexamic Acid Administration on Blood Pressure (RateTXA) Study.

The Effect of Tranexamic Acid Rate of Administration on Blood Pressure in Healthy Pregnant Women Scheduled for Elective Cesarean Delivery Under Spinal Anesthesia - A Prospective, Randomized, Double-blind, Non-inferiority Trial.


Sponsor

University of British Columbia

Enrollment

110 participants

Start Date

Mar 30, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

Tranexamic acid is a well-established treatment for post-partum hemorrhage. This study aims to examine the effect of tranexamic acid administration rates on blood pressure changes over 1 minute compared to 10 minutes in healthy pregnant patients scheduled for cesarean delivery.


Eligibility

Sex: FEMALEMin Age: 19 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a drug called Tranexamic Acid (TXA) for people with healthy participants. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 19 Years and older.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DRUGTranexamic Acid (TXA)

Study drug administration


Locations(1)

BC Women's Hospital

Vancouver, British Columbia, Canada

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06356948


Related Trials